The National Kidney Foundation has awarded the J. Michael Lazarus Distinguished Award for outstanding research contributions to clinical science and care of dialysis patients to Ramesh Khanna, MD, professor of medicine and the Karl D. Nolph Chair of Nephrology at the MU School of Medicine.
In his 45 years of nephrology practice, Khanna has worked with legendary physicians in the field to establish clinical practice standards for home dialysis therapy or continuous ambulatory peritoneal dialysis (CAPD). CAPD is a dialysis treatment performed by the patient at home for severe kidney failure. In addition, Khanna and his team established a clinical practice tool, the peritoneal equilibration test (PET), that allows for assessment and comparisons of CAPD therapy in dialysis patients. This procedure is now globally used by most clinicians.
The National Kidney Foundation also posthumously awarded Karl D. Nolph, MD, a pioneer in dialysis treatment and established leader in the School of Medicine’s Division of Nephrology. Nolph led the study of peritoneal dialysis, which improved the lives of kidney-failure patients worldwide.
“Karl was humility personified,” Khanna said. “Despite his legendary status, he was a very simple and approachable person. His door was always open for anyone to walk into his office and have a conversation. He cared for his staff and colleagues as family, and he is deeply missed.”
The National Kidney Foundation is the leading kidney disease awareness and prevention organization in the United States. The J. Michael Lazarus Distinguished Award was established to recognize individuals whose research provides fresh insight into renal replacement therapy.